Skip to main content

Management of Retroperitoneal Sarcomas

  • Chapter
  • First Online:
Book cover Sarcoma

Abstract

Retroperitoneal sarcomas (RPS) represent approximately 10–20% of all soft tissue sarcomas. The anatomical location and relationship to important structures pose unique complexities in the management of these patients. These often giant tumours have been described in literature dating back to 1761, but it is only in the last few decades that the understanding and treatment of these tumours has begun to consolidate and advance [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Tseng WW, Wang SC, Eichler CM, Warren RS, Nakakura EK. Complete and safe resection of challenging retroperitoneal tumors: anticipation of multi-organ and major vascular resection and use of adjunct procedures. World J Surg Oncol. 2011;9:143.

    Article  Google Scholar 

  2. Fisher SB, Chiang YJ, Feig BW, Cormier JN, Hunt KK, Torres KE, et al. An evaluation of the eighth edition of the American joint committee on Cancer (AJCC) staging system for retroperitoneal sarcomas using the National Cancer Data Base (NCDB): does size matter? Am J Clin Oncol. 2019;42(2):160–5.

    Article  Google Scholar 

  3. Snow HA, Hitchen TX, Head J, Herschtal A, Bae S, Chander S, et al. Treatment of patients with primary retroperitoneal sarcoma: predictors of outcome from an Australian specialist sarcoma Centre. ANZ J Surg. 2018;88(11):1151–7.

    Article  Google Scholar 

  4. Strauss DC, Hayes AJ, Thway K, Moskovic EC, Fisher C, Thomas JM. Surgical management of primary retroperitoneal sarcoma. Br J Surg. 2010;97(5):698–706.

    Article  CAS  Google Scholar 

  5. Smith HG, Panchalingam D, Hannay JA, Smith MJ, Thomas JM, Hayes AJ, et al. Outcome following resection of retroperitoneal sarcoma. Br J Surg. 2015;102(13):1698–709.

    Article  CAS  Google Scholar 

  6. Gronchi A, Strauss DC, Miceli R, Bonvalot S, Swallow CJ, Hohenberger P, et al. Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS): a report on 1007 patients from the multi-institutional collaborative RPS working group. Ann Surg. 2016;263(5):1002–9.

    Article  Google Scholar 

  7. Bonvalot S, Rivoire M, Castaing M, Stoeckle E, Le Cesne A, Blay JY, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009;27(1):31–7.

    Article  Google Scholar 

  8. Messiou C, Morosi C. Imaging in retroperitoneal soft tissue sarcoma. J Surg Oncol. 2018;117(1):25–32.

    Article  Google Scholar 

  9. Tateishi U, Yamaguchi U, Seki K, Terauchi T, Arai Y, Hasegawa T. Glut-1 expression and enhanced glucose metabolism are associated with tumour grade in bone and soft tissue sarcomas: a prospective evaluation by [18F]fluorodeoxyglucose positron emission tomography. Eur J Nucl Med Mol Imaging. 2006;33(6):683–91.

    Article  CAS  Google Scholar 

  10. Rhu J, Hyun SH, Lee KH, Jo SJ, Lee KW, Park JB, et al. Maximum standardized uptake value on (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improves outcome prediction in retroperitoneal liposarcoma. Sci Rep. 2019;9(1):6605.

    Article  Google Scholar 

  11. Morosi C, Stacchiotti S, Marchiano A, Bianchi A, Radaelli S, Sanfilippo R, et al. Correlation between radiological assessment and histopathological diagnosis in retroperitoneal tumors: analysis of 291 consecutive patients at a tertiary reference sarcoma center. Eur J Surg Oncol. 2014;40(12):1662–70.

    Article  CAS  Google Scholar 

  12. Gyorki DE, Choong PFM, Slavin J, Henderson MA. Importance of preoperative diagnosis for management of patients with suspected retroperitoneal sarcoma. ANZ J Surg. 2018;88(4):274–7.

    Article  Google Scholar 

  13. Wilkinson MJ, Martin JL, Khan AA, Hayes AJ, Thomas JM, Strauss DC. Percutaneous core needle biopsy in retroperitoneal sarcomas does not influence local recurrence or overall survival. Ann Surg Oncol. 2015;22(3):853–8.

    Article  CAS  Google Scholar 

  14. Trans-Atlantic RPSWG. Management of primary retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS working group. Ann Surg Oncol. 2015;22(1):256–63.

    Article  Google Scholar 

  15. Trans-Atlantic RPSWG. Management of Recurrent Retroperitoneal Sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS working group. Ann Surg Oncol. 2016;23(11):3531–40.

    Article  Google Scholar 

  16. Trans-Atlantic Retroperitoneal Sarcoma Working G. Management of metastatic retroperitoneal sarcoma: a consensus approach from the Trans-Atlantic retroperitoneal sarcoma working group (TARPSWG). Ann Oncol. 2018;29(4):857–71.

    Article  Google Scholar 

  17. Tattersall HL, Callegaro D, Ford SJ, Gronchi A. Staging, nomograms and other predictive tools in retroperitoneal soft tissue sarcoma. Chin Clin Oncol. 2018;7(4):36.

    Article  Google Scholar 

  18. Barakat HM, Shahin Y, Khan JA, McCollum PT, Chetter IC. Preoperative supervised exercise improves outcomes after elective abdominal aortic aneurysm repair: a randomized controlled trial. Ann Surg. 2016;264(1):47–53.

    Article  Google Scholar 

  19. Almond LM, Gronchi A, Strauss D, Jafri M, Ford S, Desai A. Neoadjuvant and adjuvant strategies in retroperitoneal sarcoma. Eur J Surg Oncol. 2018;44(5):571–9.

    Article  Google Scholar 

  20. Fairweather M, Wang J, Jo VY, Baldini EH, Bertagnolli MM, Raut CP. Surgical Management of Primary Retroperitoneal Sarcomas: rationale for selective organ resection. Ann Surg Oncol. 2018;25(1):98–106.

    Article  Google Scholar 

  21. Bonvalot S, Gaignard E, Stoeckle E, Meeus P, Decanter G, Carrere S, et al. Survival benefit of the surgical Management of Retroperitoneal Sarcoma in a reference center: a Nationwide study of the French sarcoma group from the NetSarc database. Ann Surg Oncol. 2019;26(7):2286–93.

    Article  CAS  Google Scholar 

  22. MacNeill AJ, Gronchi A, Miceli R, Bonvalot S, Swallow CJ, Hohenberger P, et al. Postoperative morbidity after radical resection of primary retroperitoneal sarcoma: a report from the transatlantic RPS working group. Ann Surg. 2018;267(5):959–64.

    Article  Google Scholar 

  23. Ferrario T, Karakousis CP. Retroperitoneal sarcomas: grade and survival. Arch Surg. 2003;138(3):248–51.

    Article  Google Scholar 

  24. Abdelfatah E, Guzzetta AA, Nagarajan N, Wolfgang CL, Pawlik TM, Choti MA, et al. Long-term outcomes in treatment of retroperitoneal sarcomas: a 15 year single-institution evaluation of prognostic features. J Surg Oncol. 2016;114(1):56–64.

    Article  Google Scholar 

  25. Teixeira FJR Jr, do Couto Netto SD, Perina ALF, Torricelli FCM, Ragazzo Teixeira L, Zerati AE, et al. Leiomyosarcoma of the inferior vena cava: survival rate following radical resection. Oncol Lett. 2017;14(4):3909–16.

    Article  Google Scholar 

  26. Blair AB, Reames BN, Singh J, Gani F, Overton HN, Beaulieu RJ, et al. Resection of retroperitoneal sarcoma en-bloc with inferior vena cava: 20 year outcomes of a single institution. J Surg Oncol. 2018;118(1):127–37.

    Article  Google Scholar 

  27. Dumitra S, Gronchi A. The diagnosis and Management of Retroperitoneal Sarcoma. Oncology (Williston Park). 2018;32(9):464–9.

    Google Scholar 

  28. Gyorki DE, Brennan MF. Management of recurrent retroperitoneal sarcoma. J Surg Oncol. 2014;109(1):53–9.

    Article  Google Scholar 

  29. Park JO, Qin LX, Prete FP, Antonescu C, Brennan MF, Singer S. Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: the one centimeter per month rule. Ann Surg. 2009;250(6):977–82.

    Article  Google Scholar 

  30. Ikoma N, Roland CL, Torres KE, Chiang YJ, Wang WL, Somaiah N, et al. Salvage surgery for recurrent retroperitoneal well-differentiated Liposarcoma: early reoperation may not provide benefit. Ann Surg Oncol. 2018;25(8):2193–200.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David E. Gyorki .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wilkinson, M.J., Downs, J., Gyorki, D.E. (2021). Management of Retroperitoneal Sarcomas. In: Choong, P.F.M. (eds) Sarcoma . Springer, Singapore. https://doi.org/10.1007/978-981-15-9414-4_19

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-9414-4_19

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-15-9413-7

  • Online ISBN: 978-981-15-9414-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics